Selective inhibitors of nitric oxide synthase (NOS) implicate a constitutive isoform of NOS in the regulation of inteuleukin-1-induced ACTH secretion in rats

Endocrine

Volumn 5, Issue 2, 1996, Pages 135-140

  Turnbull, Andrew V ^a   Rivier, Catherine ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Adrenocorticotropin; Central nervous system; Corticotropin releasing factor; Cytokines; Nitric oxide

Indexed keywords

7 NITROINDAZOLE; AMINOGUANIDINE; CORTICOTROPIN; INTERLEUKIN 1; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030478695     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Babbedge, R. C., Bland-Ward, P. A., Hart, S. L., and Moore, P. K. (1993). Br. J. Pharmacol. 110, 225-228.
2. Berkenbosch, F., Van Oers, J., del Rey, A., Tilders, F., and Besedovsky, H. (1987). Science 238, 524-526.
3. Bredt, D. S., Hwang, P. M., and Snyder, S. H. (1990). Nature 347, 768-770.
4. Brunetti, L., Preziosi, P., Ragazzoni, E., and Vacca, M. (1993). Life Sci. 53, 219-222.
5. Brunetti, L. (1994). Clin. Ter. 144, 147-153.
6. Buxton, I. L. O., Cheek, D. J., Eckman, D., Westfall, D. P., Sanders, K. M., and Keef, K. D. (1993). Circ. Res. 72, 387-395.
7. Ceccatelli, S., Lundberg, J. M., Fahrenkrug, J., Bredt, D. S., Snyder, S. H., and Hoekfelt, T. (1992). Neuroscience 51, 769-772.
8. Ceccatelli, S., Hulting, A. L., Zhang, X., Gustafsson, EL., Villar, M., and Hokfelt, T. (1993). Proc. Natl. Acad. Sci. USA 90, 11,292-11,296.
9. Chrousos, G. P. (1995). N. Engl. J. Med. 332, 1351-1362.
10. Costa, A., Trainer, P., Besser, M., and Grossman, A. (1993). Brain Res. 605, 187-192.
11. Dwyer, M. A., Bredt, D. S., and Snyder, S. H. (1991). Biochem. Biophys. Res. Comm. 176, 1136-1141.
12. Forstermann, U., Gath, I., Schwarz, P., Closs, E. I., and Kleinhart, H. (1995). Biochem. Pharmacol. 50, 1321-1332.
13. Furfine, E. S., Harmon, M. F., Paith, J. E., and Garvey, E. P. (1993). Biochemistry 32, 8512-8517.
14. Griffiths, M. J. D., Messent, M., MacAllister, R. J., and Evans, T. W. (1993). Br. J. Pharmacol. 110, 963-968.
15. Kasan, K., Hessen, B.-J., Corbett, J. A., McDaniel, M. L., Chang, K., Allison, W., Wolffenbuttel, B. H. R., Williamson, J. R., and Tilton, R. G. (1993). Eur. J. Pharmacol. 249, 101-106.
16. Iadecola, C., Zhang, F., and Xu, X. (1995). Am. J. Physiol. 268, R286-R292.
17. Lee, S., Barbanel, G., and Rivier, C. (1995) Brain Res. 705, 136-148.
18. MacKenzie, G. M., Rose, S., Bland-Ward, P. A., Moore, P. K., Jenner, P., and Marsden, C. D. (1994). Neuroreport 5, 1993-1996.
19. Mayer, B., Schmid, M., Klatt, P., and Schmidt, K. (1993). FEBS 333, 203-206.
20. Mayer, B., Klatt, P., Werner, E. R., and Schmidt, K. (1994). Neuropharmacol. 33, 1253-1259.
21. Misko, T. P., Moore, W. M., Kasten, T. P., Nickols, G. A., Corbett, J. A., Tilton, R. G., McDaniel, M. L., Williamson, J. R., and Currie, M. G. (1993). Eur. J. Pharmacol. 233, 119-125.
22. Moncada, S., Palmer, R. M. J., and Higgs, E. A. (1991). Pharmacol. Rev. 43, 109-142.
23. Moore, P. K., Babbedge, R. C., Wallace, P., Gaffen, Z. A., and Hart, S. L. (1993a). Br. J. Pharmacol. 108, 296-297.
24. Moore, P. K., Wallace, P., Gaffen, Z., Hart, S. L., and Babbedge, R. C. (1993b). Br. J. Pharmacol. 110, 219-224.
25. Rivier, C. (1994). Endocr. J. 2, 367-373.
26. Rivier, C. and Shen, G. H. (1994). J. Neurosci. 14, 1985-1993.
27. Rivier, C. (1995). Endocrinology 136, 3597-3603.
28. Salter, M., Duffy, C., Garthwaite, J., and Strijbos, P. J. L. M. (1995). Neuropharmacol. 34, 639-649.
29. Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., and Vale, W. (1987). Science 238, 522-524.
30. Sandi, C. and Guaza, C. (1995). Eur. J. Pharmacol. 274, 17-23.
31. Siaud, P., Mekaouche, M., Ixart, G., Balmefrezol, M., Givalois, L., Barbanel, G., and Assenmacher, I. (1994). Neurosci. Lett. 170, 51-54.
32. Snyder, S. H., and Dawson, T. M. (1995). Psychopharmacology: The Fourth Generation of Progress. Bloom, F. E. and Kupfer, D. J. (eds.). Raven Press, Ltd: New York, pp. 609-618.
33. Torres, G., Lee, S., and Rivier, C. (1993). Mol. Cell. Neurosci. 4, 155-163.
34. Turnbull, A. V. and Rivier, C. (1996). Endocrinology 137, 455-463.